Elite in Ascites

Wim J. Laleman

Leuven, VLG, BE 
Elite in Ascites
Leuven, VLG, BE 
OverviewLocationsClinical Research

Overview

Wim Laleman practices in Leuven, Belgium. Laleman is rated as an Elite expert by MediFind in the treatment of Ascites. Their top areas of expertise are Liver Failure, Portal Hypertension, Ascites, Liver Transplant, and Endoscopy.

Their clinical research consists of co-authoring 220 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 17 articles in the study of Ascites.

Locations

Leuven, VLG, Belgium
Other Locations
Belgium
AZ St Jan
Brugge, VLG 8000, Belgium
Edegem, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: May 09, 2025
Intervention Type: Device, Drug
Study Drug: Cisplatin-Gemcitabine
Study Phase: Phase 2/Phase 3
Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study
Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study
Enrollment Status: Completed
Publish Date: April 12, 2019
Intervention Type: Other
Study to Reduce Incidence of Post-ERCP Pancreatitis by Stent Insertion in the Main Pancreatic Duct After Unintended Cannulation of the Main Pancreatic Duct
Study to Reduce Incidence of Post-ERCP Pancreatitis by Stent Insertion in the Main Pancreatic Duct After Unintended Cannulation of the Main Pancreatic Duct
Enrollment Status: Completed
Publish Date: October 13, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

220 Total Publications

Transenteric ERCP via EUS-guided anastomosis using LAMS in patients with surgically altered anatomy.
Transenteric ERCP via EUS-guided anastomosis using LAMS in patients with surgically altered anatomy.
Journal: Gastrointestinal endoscopy
Published: July 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Laleman's expertise for a condition
ConditionClose
View All 16 Advanced Conditions
View All 34 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile